Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Frozen Fecal Microbiota Transplantation (FMT) Capsules for Depression
NCT03281044Phase 2Terminated
- Sponsor
- Universitäre Psychiatrische Kliniken Basel
- Start
- Oct 2018
- Primary completion
- Mar 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Fecal Microbiota Transplantation Capsule in major depressive disorder (MDD) (2 arms), sponsored by Universitäre Psychiatrische Kliniken Basel. Primary endpoint: Hamilton Rating Scale for Depression at 8 months. Started Oct 2018; status: terminated.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03281044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03281044.